FDA Drug Approval, N125377, YERVOY
FDA Drug Approval, N125377, YERVOY
Regular price
$149.00 USD
Regular price
Sale price
$149.00 USD
Unit price
/
per
NDA: 125377
Company: BRISTOL MYERS SQUIBB
Drug Name: YERVOY
Active Ingredients: IPILIMUMAB
Strength: 3MG
Dosage Form/Route: INJECTABLE; INJECTION
Action Date: 03/25/2011
Marketing Status: Prescription
Submission Classification:
Company: BRISTOL MYERS SQUIBB
Drug Name: YERVOY
Active Ingredients: IPILIMUMAB
Strength: 3MG
Dosage Form/Route: INJECTABLE; INJECTION
Action Date: 03/25/2011
Marketing Status: Prescription
Submission Classification:
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details